Overview

Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis

Status:
Unknown status

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the anti-atherosclerotic effect of long-term anti-inflammatory therapy (Inflaminat) in asymptomatic participants with subclinical atherosclerosis of carotid arteries.

Phase:

Phase 2

Details

Lead Sponsor:

Institute for Atherosclerosis Research, Russia